Alignment Healthcare, Inc. (NASDAQ:ALHC) Receives $23.05 Consensus Target Price from Analysts

Alignment Healthcare, Inc. (NASDAQ:ALHC) has been given an average rating of “Moderate Buy” by the fourteen analysts that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation, nine have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $23.3182.

A number of equities research analysts have recently issued reports on ALHC shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, January 21st. KeyCorp reissued an “overweight” rating and issued a $28.00 target price on shares of Alignment Healthcare in a research report on Thursday, January 22nd. Robert W. Baird set a $28.00 price target on Alignment Healthcare in a research note on Friday, January 30th. JPMorgan Chase & Co. lifted their price objective on Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research note on Thursday. Finally, Zacks Research downgraded Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 28th.

Insider Activity

In other Alignment Healthcare news, President Dawn Christine Maroney sold 282,070 shares of the firm’s stock in a transaction that occurred on Monday, December 29th. The shares were sold at an average price of $18.74, for a total value of $5,285,991.80. Following the completion of the transaction, the president owned 1,385,167 shares of the company’s stock, valued at $25,958,029.58. This trade represents a 16.92% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Robert L. Scavo sold 69,541 shares of the business’s stock in a transaction on Monday, December 29th. The stock was sold at an average price of $18.74, for a total transaction of $1,303,198.34. Following the completion of the transaction, the insider owned 503,014 shares of the company’s stock, valued at approximately $9,426,482.36. This trade represents a 12.15% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 2,103,532 shares of company stock valued at $40,529,538. 7.00% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Alignment Healthcare

Large investors have recently bought and sold shares of the stock. Royal Bank of Canada raised its position in Alignment Healthcare by 92.6% in the 1st quarter. Royal Bank of Canada now owns 92,379 shares of the company’s stock valued at $1,720,000 after purchasing an additional 44,413 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Alignment Healthcare by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,557 shares of the company’s stock worth $1,109,000 after buying an additional 2,594 shares during the period. Goldman Sachs Group Inc. raised its holdings in Alignment Healthcare by 79.1% in the first quarter. Goldman Sachs Group Inc. now owns 972,715 shares of the company’s stock valued at $18,112,000 after acquiring an additional 429,703 shares in the last quarter. Woodline Partners LP purchased a new position in Alignment Healthcare in the first quarter worth approximately $2,142,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Alignment Healthcare by 16.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 307,655 shares of the company’s stock worth $5,729,000 after acquiring an additional 44,452 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Stock Up 2.8%

Shares of NASDAQ:ALHC opened at $21.75 on Tuesday. The company has a market capitalization of $4.35 billion, a price-to-earnings ratio of -181.25, a PEG ratio of 5.73 and a beta of 1.16. Alignment Healthcare has a 12-month low of $11.63 and a 12-month high of $23.87. The business has a 50-day moving average price of $20.79 and a 200 day moving average price of $17.80. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.